Thank you for your question. The intent of this particular value set is to represent medications given to the patient during hospitalization. Generally speaking, RxNorm value sets used in eCQMs include only semantic clinical drug level terms (except when the value set is intended to be used in the context of a medication allergy or negation statement). The inclusion of additional term types in medication value sets is under consideration, as there are complexities associated with this. For example, it may not always be appropriate to include ingredient-level term types in value sets where the strength or dose form of a medication may impact the intent of the value set. While vendors/providers should report the drug entities in patient data using the generalized drug concepts included in the defined value sets, it is acceptable to map other term types (e.g. branded drug names) to the terms included in medication value sets. You can find more information and implementation guidance surrounding medication value sets in the eCQM Logic and Implementation Guidance document (Sections 6.2 through 6.4)., which is published in CMS's eCQM library ( https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/eCQM_Library.html), along with eCQM specifications.